Cardiocore Adds Daniel Goodman, MD to its Cardiac Safety Consulting Team Fastest Growing Cardiac Core Lab Expands its International Scientific Leadership 15.June.2007, Bethesda, MD - Cardiocore, a premier centralized cardiac safety testing laboratory, announced today that industry expert Daniel B. Goodman, MD has joined its scientific consulting team. Working alongside Cardiocore's Chief Medical Officer Lawrence Satin, MD, FACC, Dr. Goodman will enable Cardiocore to expand its best-in-class consulting services to support its growing base of pharmaceutical and biotech customers. "Dan Goodman is a true founding father of our industry," said Dr. Satin, "and I am honored to have him as a consulting partner and a friend. It's hard to think of an individual more aligned with Cardiocore's commitment to scientific excellence. Dan has helped develop the best practices for cardiac safety testing in clinical pharmacology units, and I am delighted that Cardiocore's Thorough QT customers will benefit from his expertise." Dr. Goodman, a graduate of Yale University and Cornell University Medical School, founded the leading-edge Cardiology for Clinical Trials in 1992. He directed medical affairs in the cardiac safety services branch of a major CRO from 1994 until April 2007. In that capacity he developed protocols, produced cardiac safety reports and oversaw both global Phase III and Thorough QT studies. Goodman's work is well-recognized and well-published, establishing him as an international thought leader in the area of cardiac safety testing. "Cardiocore has always put sponsors' need for scientific quality ahead of all other interests," explained Dr. Goodman, "and that's why I have decided to join their team of consulting experts. Cardiocore's integrity raises the bar for our whole industry, and I'm proud to be part of it." Technology expert and Cardiocore CEO Jennifer Cotteleer added, "Larry and Dan are both industry pioneers and technology innovators. It's rare to find individuals who combine such depth of experience with such powerful forward vision. Their collaboration will continue the trend of sponsors turning to Cardiocore to find the safest, most efficient, most advanced solutions for their cardiac safety testing needs." Dr. Goodman's expertise will be available to Cardiocore's customers through an exclusive consulting agreement with respect to core labs between Cardiocore and Entelligent Solutions where he serves as Medical Director. Cardiocore and Dr. Goodman will launch their expanded offering at the 43rd DIA Annual Meeting, in Atlanta, on June 17 through June 21. About Cardiocore Cardiocore has provided superior centralized cardiac testing services to the pharmaceutical industry for 14 years. Services include centralized electrocardiographic (ECG) analysis, Holter monitoring, statistical analysis and consulting services such as protocol design. The company is experienced in design and implementation of Thorough QT Trials and cardiac safety testing in Phase I, II and III clinical trials. These services are supported by the company's CardioCorrect® system featuring the proprietary HolterGateway™ and CardioPortal™. Cardiocore's US headquarters is located in Bethesda, Maryland, and its European subsidiary, Cardiocore Limited, is located in London, England. About Entelligent Solutions Entelligent Solutions provides professional services, products, and solutions to private and public entities looking to enhance the knowledge and quality-of-life of their customers. Main offerings include medical consulting, communications and social marketing, and information technology services.